Use the PDR®, Section 2, Brand and Generic Name Index, to find another product name for each drug listed in the Representative Antineoplastic Drugs table on pages 468–469 of this chapter.
Representative Antineoplastic Drugs | ||||
Category, Namea, and Route | Uses and Diseases | Actions | Usual Doseb and Special Instructions | Side Effects and Adverse Reactions |
Alkylating Drugs | ||||
Mechlorethamine (Mustargen) IV | Hodgkin’s disease, lymphosarcoma | Inhibits rapidly growing cells | IV dosage according to body weight, adjusted to highest nontoxic dose; assist patient with oral hygiene; give adequate fluid; follow physician’s orders carefully; note length of time for IV infusion; watch for pain at infusion site | Nausea, vomiting, anorexia, bleeding, bruising, metallic taste |
Carmustine (BiCNU) IV | Brain tumor, Hodgkin’s disease, lymphomas, melanoma | Inhibits rapidly growing cells | IV dosage according to surface area, pain at injection site common | Blood and liver problems, nausea, vomiting, diarrhea |
Temozolomide (Temodar) Oral | Brain cancer | Inhibits rapidly growing cells | May be taken orally at home; adjust dose based on neutrophil and platelet counts | Thrombocytopenia, neutropenia, nausea, vomiting, constipation, headache, fatigue |
Antimetabolites | ||||
Fluorouracil 5-Fluorouracil 5-FU (Adrucil) IV, topical | Cancer of the breast, colon, rectum, stomach, pancreas, cervix, and bladder | Inhibits DNA synthesis | IV dosage according to body weight; avoid extravasation(discharge of blood or other substances into tissues) | Anorexia, nausea, vomiting, stomatitis, diarrhea, weakness, dermatitis |
Mercaptopurine (Purinethol) Oral | Leukemias | Inhibits DNA synthesis | Oral dosage according to body weight, adjusted to highest nontoxic dose | Blood and liver problems, anorexia, nausea, vomiting |
AntibioticAntitumor | ||||
Dactinomycin (Cosmegen) IV | Cancer of the testes and uterus, Wilms’ tumor | Inhibits cell reproduction | IV dosage according to body weight, adjusted to highest nontoxic dose. Drug is corrosive; avoid contact with skin; avoid extravasation | Nausea, vomiting, stomatitis, blood problems, bruising, loss of hair |
Epirubicin (Ellence) IV | Breast cancer as an adjunct therapy | Inhibits DNA synthesis | Administer IV slowly over 3 to 5 minutes | Leukopenia, neutropenia, anemia, nausea, vomiting, mucositis, alopecia, amenorrhea |
Miscellaneous Antineoplastic Drugs | ||||
Tamoxifen (Nolvadex) Oral | Cancer of the breast | Acts as estrogen antagonist | 10 mg po bid to tid | Nausea, vomiting, anorexia, rash, vaginal discharge, depression, dizziness, hair thinning, or partial loss of hair |
aTrade names given in parentheses are examples only. Check current drug references for a complete listing of available products.
bAverage adult doses are given. However, dosages are determined by a physician and vary with the purpose of the therapy and the particular patient. The doses presented here are for general information only.
Answers will vary depending on the edition of the PDR® that is used.